When maintained in vivo as tumor xenografts in immune-compromised NSG mice for 3 wk, each of the three IKKα deficient human NSCLC lines presented significantly greater adenocarcinoma tumor burdens than their IKKαWT controls. Here, CHUK is linked to non-small cell lung carcinoma.